General · 22 April 2026
UK Launches Major Bird Flu Vaccine Trial
A Phase 3 trial of Moderna's mRNA bird flu vaccine has launched in the UK and US, recruiting around 4,000 volunteers across 26 sites. The vaccine targets the H5N1 strain and uses the same technology as Covid jabs. Scientists aim to confirm it is safe and generates a strong immune response, guarding against a potential future pandemic.
Reported by BBC · How we write briefs
